Clinically supervised care
Every route begins with an assessment so treatment is only considered where it is appropriate and safe.
Start your journey with Manchester Chemist through a medically supervised weight management service designed around safety, suitability and transparent treatment options.
This section gives the page a stronger mid-funnel explanation of the service while keeping the copy grounded in suitability, supervision and transparent comparison.
Every route begins with an assessment so treatment is only considered where it is appropriate and safe.
Patients can compare injectable and capsule options in one place before deciding whether to continue.
The copy reassures patients that weight management is more than a product list and includes practical pharmacist-led guidance.
Use this short comparison block near the top of the page so patients can understand the main routes before reading the full pricing section.
Weekly injectable treatment designed to help regulate appetite as part of a supervised weight management plan.
Weekly treatment that may suit patients looking for a clinically reviewed injectable option.
Daily injectable route for patients following a structured plan with regular review.
Oral weight management option for patients who may prefer a non-injectable route.
This section keeps the pricing comparison clear for patients while staying grounded in clinical suitability rather than sales-only messaging.
Mounjaro is a weekly injectable option that may be considered after a full clinical assessment.
| Variation | Price |
|---|---|
| 2.5mg | £150 |
| 5mg | £170 |
| 7.5mg | £220 |
| 10mg | £240 |
| 12.5mg | £260 |
| 15mg | £280 |
Wegovy is another weekly route that may be considered for patients who meet the prescribing criteria.
| Variation | Price |
|---|---|
| 0.25mg | £130 |
| 0.5mg | £150 |
| 1mg | £170 |
| 1.7mg | £200 |
| 2.4mg | £230 |
Saxenda is a daily injectable route that may suit patients following a structured private management plan.
| Variation | Price |
|---|---|
| 6mg/ml | £70 |
Orlistat is an oral option that may suit patients who prefer a non-injectable route where appropriate.
| Variation | Price |
|---|---|
| 120mg hard capsules - pack of 84 | £50 |
This page should reassure patients that the service is about more than medication alone. The strongest SEO and patient-trust version of the page explains why assessment, safety and ongoing review all matter.
Keeping this process explicit helps the page rank for informational intent while also reducing uncertainty for patients who are considering treatment.
Complete the initial route so the pharmacy can begin assessing whether treatment may be suitable.
Patients are asked about medical history, current medicines, previous treatment and weight management goals.
A pharmacist reviews the information to determine whether treatment is appropriate and which route may fit best.
If appropriate, the patient can continue with the recommended treatment route and clearly displayed pricing.
Where relevant, follow-up guidance helps patients continue safely and with more confidence.
These are the kinds of questions patients often ask before starting a private weight management consultation, so keeping them visible also improves the page for broader search intent.
Weight loss medication is usually most effective when combined with lifestyle change and realistic long-term support rather than viewed as a standalone fix.
Eligibility depends on factors such as weight, health conditions, current medicines and wider clinical history. A full assessment is needed before treatment is considered.
Potential side effects are discussed before treatment proceeds so patients understand what to expect and when to ask for further advice.
If injectable options are not appropriate or not preferred, an oral route such as Orlistat may be considered depending on your assessment.
Use the eligibility check to start the consultation route so the pharmacy team can review whether treatment may be suitable for you.